Australian Stroke Alliance
The Australian Stroke Alliance is a non-profit national research organisation, founded in 2020 and led by Professors Stephen Davis and Geoffrey Donnan, that develops pre-hospital stroke care technology — the Zeus telehealth platform, Mobile Stroke Units, and portable brain scanners — to deliver time-critical treatment to rural, remote and Indigenous Australians.
- Company typePrivate
- Founded2020
- HeadquartersParkville, Australia
- Headcount11–50
- GTM typeB2B
- OfferingServices
What Australian Stroke Alliance does
The Australian Stroke Alliance is a private, non-profit national research organisation founded in 2020 and headquartered at the Royal Melbourne Hospital in Parkville, Victoria. It was co-founded by Professors Stephen Davis AO and Geoffrey Donnan AO, both Past-Presidents of the World Stroke Organization, to address what it describes as a postcode-driven inequity in access to time-critical stroke care across Australia's vast geography. The organisation coordinates a consortium of seven principal partners — Royal Melbourne Hospital, Royal Flying Doctor Service, Ambulance Victoria, Stroke Foundation, RMIT University, the Council of Ambulance Authorities, and the University of Melbourne — and collaborates with over 40 national agencies.
Its core technology stack comprises three integrated platforms: the Zeus cloud-based stroke telehealth system (DICOM image viewing, secure videoconferencing, ML-driven resource allocation, hospital pre-notification); Mobile Stroke Units (CT-equipped ambulances with embedded stroke teams, operational since 2017 in Melbourne and now expanding to Monash Health and Sydney); and ultra-lightweight portable brain scanners being developed with RMIT and EMVision for integration into road and air ambulances. Supporting programmes include the Darak Indigenous leadership framework, the Education Platform for rural clinicians, a Mechanical Thrombectomy White Paper, and a new remote robotics programme (Remedy Robotics) for endovascular thrombectomy.
The Alliance does not operate a commercial revenue model. It is funded principally by the Australian Government's Medical Research Future Fund (MRFF) Frontiers initiative, supplemented by over $4 million in anonymous philanthropic donations. "Customers" are effectively Australian stroke patients across rural, remote, Indigenous, and metropolitan segments, with the Alliance serving as an R&D and coordination body rather than a billing entity. Operational scale targets a $15.6 billion economic benefit, 235,000 disability-free life-years, 45,000 DALYs saved, and 1,700 new medtech jobs by 2050.
Australian Stroke Alliance firmographics
Firmographics- Name
- Australian Stroke Alliance
- Legal name
- The Australian Stroke Alliance
- Website
- https://austrokealliance.org.au
- Company type
- Private
- Founded year
- 2020
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- The Australian Stroke Alliance is a non-profit national research organisation, founded in 2020 and led by Professors Stephen Davis and Geoffrey Donnan, that develops pre-hospital stroke care technology — the Zeus telehealth platform, Mobile Stroke Units, and portable brain scanners — to deliver time-critical treatment to rural, remote and Indigenous Australians.
- Ownership category
- akta.pro rank
Australian Stroke Alliance industry classification
Industry- Product category
- Stroke Care Research Services
- NAICS
- Ambulance Services (621910)
- SIC
- Services-Offices & Clinics Of Doctors Of Medicine (8011)
- akta.pro primary industry
- Stroke & Vascular Neurology (HLAKAIAG)
- akta.pro secondary industries
- Neurology Telemedicine Platforms (HLALAGAC), Thrombectomy, Embolic Protection & Stroke Intervention Devices (HLAHAFAJ), Medical-Grade Device Connectivity & Device Management (MDM) (HLACAFAG)
Keywords
Where Australian Stroke Alliance is headquartered
LocationHeadquarters
- HQ city
- Parkville
- HQ country
- Australia
- HQ region
- Oceania
Offices1 record
Markets served
Australian Stroke Alliance business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Technology or R&D, Operations, Marketing or Sales, Others
Distribution channels4 records
Marketing channels7 records
Australian Stroke Alliance product offering
Product offeringCore offering
The Australian Stroke Alliance delivers pre-hospital stroke diagnosis and treatment through the Zeus telehealth platform, Mobile Stroke Units (MSUs), and portable brain scanners deployed in road and (planned) air ambulances. It complements these technologies with the Darak community and education program and a remote robotics system to support earlier triage, intervention, and improved stroke outcomes across Australia.
Product overview
The Australian Stroke Alliance offers a suite of interconnected prehospital stroke care products and services designed to deliver urgent treatment to stroke patients across Australia's vast geography. The core offering consists of the Zeus telehealth platform for connecting rural and remote patients with city-based neurologists, Mobile Stroke Units (MSU) equipped with CT brain imaging, and lightweight portable brain scanners for integration into road and air ambulances. Supporting infrastructure includes the Darak program for Indigenous community engagement, comprehensive education and training resources for rural clinical workforce, and evaluation frameworks for measuring health outcomes. These components work together to address the 'golden hour' critical window for stroke treatment, particularly benefiting rural, remote, and Indigenous communities who currently have limited access to specialist stroke care.
Differentiator
Problem solved
Functional benefit
Brands
- Zeus: Australia's national telehealth platform for stroke care, designed to connect rural and remote patients and first responders with city-based neurologists 24/7.
- Darak
- Mobile Stroke Unit (MSU)
Products and services
- Zeus Stroke Telehealth Platform A telehealth platform that connects paramedics in the field with neurologists and stroke specialists to enable remote assessment, triage, and treatment decisions for suspected stroke patients before they reach hospital.
- Mobile Stroke Unit (MSU) Road-based ambulances equipped with onboard brain imaging and point-of-care stroke treatment capability, allowing diagnosis and therapy to begin at the scene or during transport rather than at hospital.
- Portable Brain Scanners Portable brain scanning devices designed to be carried in MSUs and (planned) air ambulances, enabling rapid brain imaging of stroke patients in the field.
- Remote Robotics System A remote robotics capability aimed at supporting stroke intervention when specialist clinicians are not physically present at the patient's location.
- Darak Program A community and education program delivered by the Alliance that supports stroke awareness, workforce training, and capability building for pre-hospital stroke care.
- Australian Stroke Alliance Education Platform An education and training platform supporting clinicians, paramedics, and researchers in pre-hospital stroke care, complementing the Alliance's clinical and research activities.
Quantifiable outcome
- 75 minutes faster treatment compared to Australian national median
- +8 more outcomes
Companies that use Australian Stroke Alliance
Customer profileSegments4 records
Ideal customer profiles2 records
Australian Stroke Alliance technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability6 records
Feature5 records
Australian Stroke Alliance partnerships and signals
Strategic signalPartnerships
15 partnerships are on record, tiered significant, core and supporting.
- Remedy RoboticssignificantStrategic partnership to deploy Remedy's remotely operated robotic system for endovascular thrombectomy across hospitals in Australia. Collaboration focuses on regulatory approval and expanding access to robotic stroke treatment, especially in rural and remote areas.
- Royal Melbourne HospitalcorePrincipal partner and base for the Melbourne Mobile Stroke Unit program. Provides clinical expertise, research facilities, and hosts the Melbourne Brain Centre. Key institution in the alliance's pre-hospital stroke care initiatives.
- Royal Flying Doctor ServicecorePrincipal partner providing aeromedical expertise for developing the world's first air stroke ambulance. Conducted survey of 650+ Australians on stroke care experiences. Covers 7.69 million square kilometres of remote Australia.
- Ambulance VictoriacorePrincipal partner operating mobile stroke ambulances in Victoria and providing paramedic training for stroke care. Key partner in the Victorian Stroke Telemedicine service.
- Stroke FoundationcorePrincipal partner and Australia's peak consumer organisation for stroke, providing consumer engagement, stroke survivor stories, and advocacy support for the alliance.
- RMIT UniversitycorePrincipal partner providing engineering expertise for ultra-lightweight brain scanner development and air mobile stroke unit design. Engineering Lead Professor Cees Bil contributes aerospace engineering and autonomous systems expertise.
- Council of Ambulance Authorities (CAA)corePrincipal partner representing ambulance authorities across Australia, providing strategic coordination for pre-hospital stroke care implementation nationally.
- The University of MelbournecorePrincipal partner hosting the Melbourne Brain Centre and providing research leadership through Professors Geoffrey Donnan and Stephen Davis, co-leads of the Australian Stroke Alliance.
- TitancoreJoint venture partner contributing to the alliance's commercialisation efforts. Professor Stan Skafidas chairs Titan Neuroscience's Commercial and Scientific Advisory Committee.
- South Australia HealthsignificantPartner health service implementing the Zeus telehealth platform for telestroke care across South Australia.
- Northern Territory HealthsignificantPartner health service implementing Zeus telehealth platform for stroke care in the Northern Territory, particularly important for remote Indigenous communities.
- Hunter Health Innovation PrecinctsupportingPartner in NSW implementing Zeus telehealth platform for stroke care in the Hunter region.
- Liverpool HospitalsupportingPartner hospital in Southwestern Sydney Local Health District implementing Zeus telehealth platform.
- AIATSIS (Australian Institute of Aboriginal and Torres Strait Islander Studies)supportingPartner providing Core cultural training modules for the Darak program, enhancing understanding of Aboriginal and Torres Strait Islander culture, history and society.
- EMVisionsignificantTechnology partner developing the EMU brain scanner for portable stroke diagnosis, being tested as part of the alliance's lightweight imaging program.
Scale indicators11 records
Recent moves6 records
Expansion highlights5 records
Australian Stroke Alliance competitors and assessment
Company assessmentBroad incumbents
- Penumbra: Global leader in thrombectomy and neurovascular devices, with stroke-recovery systems used in comprehensive stroke centres. Comparable to ASA's stroke intervention focus and the Remedy Robotics thrombectomy partnership, but operates as a commercial device incumbent rather than a research consortium.
- Medtronic Neurovascular: Large medical-device incumbent offering a broad portfolio of neurovascular and thrombectomy products. Comparable to ASA's thrombectomy-access agenda but operates at much larger commercial scale globally.
- Siemens Healthineers: Major medical imaging vendor with mobile CT and stroke imaging solutions used in hospital and pre-hospital settings. Comparable to the CT imaging backbone of ASA's Mobile Stroke Units, though operates as a broad imaging incumbent rather than a research consortium.
- Stryker Neurovascular: Major neurovascular device company offering coils, stents, and thrombectomy tools used in mechanical thrombectomy. Comparable to ASA's mechanical thrombectomy white paper and Remedy Robotics partnership addressing gaps in thrombectomy access.
Direct peers
- Viz.ai: Specialises in AI-driven care coordination for neurovascular conditions, with automated image sharing and clinician notification workflows that mirror Zeus's pre-notification and DICOM-sharing capabilities for telestroke.
- Brainomix: Develops AI-based stroke imaging biomarkers (e.g., e-Stroke suite) used in pre-hospital and emergency decision-making. Directly comparable to ASA's neuroimaging analytics capability within Zeus and Melbourne Brain Centre.
- RapidAI: Provider of AI-powered neuroimaging and workflow software for stroke triage and treatment. Highly comparable to ASA's Zeus platform, which similarly uses imaging analytics and decision-support tools to accelerate pre-hospital and in-hospital stroke care.
- EMVision: Australian-listed developer of portable, lightweight brain imaging scanners (including the First Responder device) integrated with emergency vehicles. Directly comparable to ASA's portable brain scanner program and a named technology partner of the Alliance.
Emerging players
- Hyperfine: Pioneer of portable, point-of-care MRI systems designed for bedside and emergency use. Comparable to ASA's portable brain scanner initiative aimed at bringing imaging into ambulances and remote settings.
- Remedy Robotics: Developer of remotely operated robotic systems for endovascular thrombectomy. Strategic partner of ASA, with shared focus on expanding thrombectomy access to rural and remote hospitals in Australia.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks6 records
Key highlights7 records
Customer concentration
Australian Stroke Alliance social profiles
Digital presenceAustralian Stroke Alliance financial estimates
Financial estimateRevenue estimate
Valuation estimate
Australian Stroke Alliance leadership team
Management profileNumber of profiles
Profiles10 records
Australian Stroke Alliance funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Australian Stroke Alliance M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Australian Stroke Alliance
What does Australian Stroke Alliance do?
The Australian Stroke Alliance delivers pre-hospital stroke diagnosis and treatment through the Zeus telehealth platform, Mobile Stroke Units (MSUs), and portable brain scanners deployed in road and (planned) air ambulances. It complements these technologies with the Darak community and education program and a remote robotics system to support earlier triage, intervention, and improved stroke outcomes across Australia.
Is Australian Stroke Alliance a public or private company?
Australian Stroke Alliance is a private company. It is classified as nonprofit foundation owned and is currently operating.
When was Australian Stroke Alliance founded?
Australian Stroke Alliance was founded in 2020. It employs 11 to 50 people.
Where is Australian Stroke Alliance based?
Australian Stroke Alliance is headquartered in Parkville, Australia, in the Oceania region.
Who are Australian Stroke Alliance's main competitors?
Broad incumbents on record are Penumbra, Medtronic Neurovascular, Siemens Healthineers and Stryker Neurovascular. Direct peers are Viz.ai, Brainomix, RapidAI and EMVision. Emerging players are Hyperfine and Remedy Robotics.
Does Australian Stroke Alliance have an API?
No public API is recorded for Australian Stroke Alliance.
What industry is Australian Stroke Alliance in?
Australian Stroke Alliance's product category is Stroke Care Research Services. Its primary akta.pro industry code is HLAKAIAG, Stroke & Vascular Neurology, with a secondary code of HLALAGAC, Neurology Telemedicine Platforms. Its NAICS code is 621910 and its SIC code is 8011.